Abstract
The compatibility caused by injection of Nicarpine® 10 mg / 10 mL (Nicarpine®) from a side tube into an intravenous line infused with Replas® 1 Injection (Replas® 1) and Novo-Heparin® 10,000 units / 10 mL for Injection (Novo-Heparin®) was investigated. We observed a mixed solution of each constituent of Replas® 1 and Novo-Heparin® with Nicarpine®, and measured the IR spectrum of the precipitate and the 1H-NMR spectrum of a saturated solution of the mixture of heparin and nicardipine. Our findings suggested that the compatibility was caused by an intermolecular interaction between heparin and nicardipine when in a 1:2 ration via the formation of a salt between the sulfate group and/or the carboxylic group of heparin and the amino group of nicardipine.